QuVa Pharma Announces Successful Capital Raise
Sugar Land, TX – July 24, 2018 – QuVa Pharma, Inc. today announced it has raised additional debt funding of up to $41 million to support business growth initiatives impacting … Continued
Sugar Land, TX – July 24, 2018 – QuVa Pharma, Inc. today announced it has raised additional debt funding of up to $41 million to support business growth initiatives impacting … Continued
BIRMINGHAM, June 20, 2018 – New Capital Partners (NCP), a private equity firm, today announces that is has acquired Collect Rx, a leading revenue cycle management (RCM) company. The company … Continued
CHICAGO, IL; March 9, 2018 – Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, has … Continued
Agreement Provides Company with Increased Financial Flexibility and Extended Amortization Period Plano, Texas, February 20, 2018 – Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it … Continued
ALEXANDRIA, VA, December 19, 2017 – Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of … Continued
ALEXANDRIA, Va. and SAN JOSE, Calif.– November 29, 2017 – Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced … Continued